Week In Review: Shanghai Junshi Biosciences Files For $500 Million Hong Kong IPO

Shanghai Junshi Biosciences has filed for a Hong Kong IPO that is expected to raise up to $500 million. Junshi is developing a pipeline of 13 biologic drugs, including immuno-oncology treatments. Its …
( read original story …)


Related Post